Cytotoxic activity against human tumor Aro cell line
|
Homo sapiens
|
0.1
nM
|
|
Cytotoxic activity against human tumor PT45 cell line
|
Homo sapiens
|
100.0
nM
|
|
Cytotoxic activity against human tumor C8305 cell line
|
Homo sapiens
|
100.0
nM
|
|
Cytotoxic activity against human tumor HT-29 cell line
|
Homo sapiens
|
100.0
nM
|
|
Cytotoxic activity against human tumor MCF-7 cell line
|
Homo sapiens
|
10.0
nM
|
|
Cytotoxic activity against human tumor SW 13 cell line
|
Homo sapiens
|
1.0
nM
|
|
Cytotoxic activity against human tumor Hep 3B cell line
|
Homo sapiens
|
100.0
nM
|
|
Cytotoxic activity against human tumor Hep G2 cell line
|
Homo sapiens
|
100.0
nM
|
|
Cytotoxic activity against human tumor Igrov-1 cell line
|
Homo sapiens
|
10.0
nM
|
|
Cytotoxic activity against human tumor Ovcar-3 cell line
|
Homo sapiens
|
10.0
nM
|
|
Cytotoxic activity against human tumor NCI-H295 cell line
|
Homo sapiens
|
100.0
nM
|
|
Cytotoxic activity against human tumor PLC/PRF/5 cell line
|
Homo sapiens
|
100.0
nM
|
|
Cytotoxic activity against human tumor Mia Paca 2 cell line
|
Homo sapiens
|
10.0
nM
|
|
Cytotoxicity against human SMMC7721 cells after 48 hrs
|
Homo sapiens
|
26.7
ug.mL-1
|
|
Cytotoxicity against human HL60 cells after 48 hrs
|
Homo sapiens
|
11.2
ug.mL-1
|
|
Cytotoxicity against human L02 cells after 48 hrs
|
Homo sapiens
|
28.4
ug.mL-1
|
|
Cytotoxicity against human LNCAP cells after 72 hrs by alamar blue assay
|
Homo sapiens
|
2.9
nM
|
|
Cytotoxicity against human PC3 cells after 72 hrs by alamar blue assay
|
Homo sapiens
|
11.0
nM
|
|
Antiplasmodial activity against Plasmodium falciparum 3D7 after 72 hrs by SYBR green assay
|
Plasmodium falciparum
|
100.0
nM
|
|
Antiplasmodial activity against Plasmodium falciparum D10 after 72 hrs by SYBR green assay
|
Plasmodium falciparum D10
|
199.53
nM
|
|
Antiplasmodial activity against Plasmodium falciparum Dd2 after 72 hrs by SYBR green assay
|
Plasmodium falciparum
|
100.0
nM
|
|
Antiplasmodial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green assay
|
Plasmodium falciparum
|
50.12
nM
|
|
PUBCHEM_BIOASSAY: Luminescence Cell-Based HTS Dose Confirmation to Identify Inhibitors of of 5'UTR Stem-Loop Driven Alpha-Synuclein mRNA Translation in H4 Neuroglioblastoma Cells. (Class of assay: confirmatory) [Related pubchem assays: 1813 (Primary HTS), 1827 (Project Summary)]
|
None
|
55.0
nM
|
|
PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Response HTS to Identify Inhibitors of Luciferase Translation or Activity in H4 Neuroglioblastoma Cells. (Class of assay: confirmatory) [Related pubchem assays: 1813 (Primary HTS), 1827 (Project Summary)]
|
None
|
100.0
nM
|
|
PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Response to Identify Inhibitors of Luciferase Translation or Activity in H4-C Neuroglioblastoma Cells. (Class of assay: confirmatory) [Related pubchem assays: 1813 (Primary HTS), 1827 (Project Summary)]
|
None
|
47.0
nM
|
|
PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Response to Identify Inhibitors of 5'UTR Stem-Loop Driven Prion Protein mRNA Translation in H4-C Neuroglioblastoma Cells. (Class of assay: confirmatory) [Related pubchem assays: 1827 (Project Summary), 1813 (Primary HTS)]
|
None
|
63.0
nM
|
|
PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Response HTS to Identify Inhibitors of 5'UTR Stem-Loop Driven Prion Protein mRNA Translation in H4 Neuroglioblastoma Cells. (Class of assay: confirmatory) [Related pubchem assays: 1827 (Project Summary), 1813 (Primary HTS)]
|
None
|
100.0
nM
|
|
PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Confirmation HTS to Identify Inhibitors of of 5'UTR Stem-Loop Driven Alpha-Synuclein mRNA Translation in H4 Neuroglioblastoma Cells. (Class of assay: confirmatory) [Related pubchem assays: 1827 (Project Summary), 1813 (Primary HTS)]
|
None
|
100.0
nM
|
|
Inhibition of electric eel AChE at 2 mg/ml by Ellman's method
|
Electrophorus electricus
|
10.9
%
|
|
Inhibition of horse BChE at 2 mg/ml by Ellman's method
|
Equus caballus
|
2.81
%
|
|
Cytotoxicity against human NFF cells after 72 hrs by alamar blue assay
|
Homo sapiens
|
17.0
nM
|
|
Cytotoxicity against human PC3 cells after 72 hrs by alamar blue assay
|
Homo sapiens
|
15.0
nM
|
|
Cytotoxicity against human HEK cells after 72 hrs by alamar blue assay
|
Homo sapiens
|
31.0
nM
|
|
Cytotoxicity against human LNCAP cells after 72 hrs by alamar blue assay
|
Homo sapiens
|
6.1
nM
|
|
Cytotoxicity against human HeLa cells after 72 hrs by alamar blue assay
|
Homo sapiens
|
36.0
nM
|
|
Cytotoxicity against human A549 cells after 72 hrs by alamar blue assay
|
Homo sapiens
|
20.0
nM
|
|
Cytotoxicity against human NFF cells assessed as inhibition of cell viability after 72 hrs by alamar blue assay
|
Homo sapiens
|
16.9
nM
|
|
Cytotoxicity against human PC3 cells assessed as inhibition of cell viability after 72 hrs by alamar blue assay
|
Homo sapiens
|
15.3
nM
|
|
Cytotoxicity against human HeLa cells assessed as inhibition of cell viability after 72 hrs by alamar blue assay
|
Homo sapiens
|
35.8
nM
|
|
PubChem BioAssay. Luminescence-based cell-based high throughput dose response assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1. (Class of assay: confirmatory)
|
None
|
277.93
nM
|
|
Cytotoxicity against human KB cells after 72 hrs by SRB assay
|
Homo sapiens
|
20.0
nM
|
|
Cytotoxicity against human Lu1 cells after 72 hrs by SRB assay
|
Homo sapiens
|
480.0
nM
|
|
Cytotoxicity against human HepG2 cells after 72 hrs by SRB assay
|
Homo sapiens
|
690.0
nM
|
|
Cytotoxicity against human MCF7 cells after 72 hrs by SRB assay
|
Homo sapiens
|
510.0
nM
|
|
Antiproliferative activity against human BT549 cells after 48 hrs by MTT assay
|
Homo sapiens
|
54.72
nM
|
|
Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
|
Homo sapiens
|
171.5
nM
|
|
Antiproliferative activity against human MDA-MB-231 cells after 48 hrs by MTT assay
|
Homo sapiens
|
116.6
nM
|
|
Antiproliferative activity against human PC3 cells after 48 hrs by MTT assay
|
Homo sapiens
|
27.6
nM
|
|
Antiproliferative activity against human DU145 cells after 48 hrs by MTT assay
|
Homo sapiens
|
72.3
nM
|
|
Antibacterial activity against Klebsiella pneumoniae MDR ATCC 70063 (CO-ADD:GN_003); MIC in CAMBH media using NBS plates, by OD(600)
|
Klebsiella pneumoniae
|
1.69
%
|
|
Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 (CO-ADD:GN_042); MIC in CAMBH media using NBS plates, by OD(600)
|
Pseudomonas aeruginosa
|
1.62
%
|
|
Antifungal activity against Candida albicans ATCC 90028 (CO-ADD:FG_001); MIC in YNB media using NBS plates, by OD630
|
Candida albicans
|
-0.39
%
|
|
Antifungal activity against Cryptococcus neoformans H99 ATCC 208821 (CO-ADD:FG_002); MIC in YNB media using NBS plates, by Resazurin OD(600-570)
|
Cryptococcus neoformans
|
-1.83
%
|
|
Antibacterial activity against Staphylococcus aureus MRSA ATCC 43300 (CO-ADD:GP_020); MIC in CAMBH media using NBS plates, by Resazurin F(560/590)
|
Staphylococcus aureus subsp. aureus
|
-14.43
%
|
|
Antibacterial activity against Acinetobacter baumannii ATCC 19606 (CO-ADD:GN_034); MIC in CAMBH media using NBS plates, by Resazurin F(560/590)
|
Acinetobacter baumannii
|
-6.71
%
|
|
Antibacterial activity against Escherichia coli ATCC 25922 (CO-ADD:GN_001); MIC in CAMBH media using NBS plates, by Resazurin F(560/590)
|
Escherichia coli
|
2.79
%
|
|